Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01210391 · ClinicalTrials.gov registry record · NA
Growth of Infants Fed an Extensively Hydrolyzed Infant Formula
A NA study, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- NA
- Development phase
- 282
- Enrollment target
NCT01210391 is a NA study that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 282 participants.
The verdict
NCT01210391, a NA study, has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- NA
- Development phase
- 282 participants
- Enrollment target
Study Summary
The primary objective of the clinical trial is to compare growth in infants (expressed as weight gain in g/day) consuming a new extensively hydrolyzed formula (EHF) to infants consuming a commercially available EHF.
Interventions
- OTHER Extensively hydrolyzed casein infant formula
- OTHER Extensively hydrolyzed whey infant formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 282 participants |
| Start Date | 2010-11 |
| Est. Completion | 2013-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01210391
The ClinicalTrials.gov registry entry for NCT01210391 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 282 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Société des Produits Nestlé (SPN), which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Extensively hydrolyzed casein infant formula is the first listed.
NCT01210391 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01210391 about?
NCT01210391 is a clinical study titled "Growth of Infants Fed an Extensively Hydrolyzed Infant Formula". The primary objective of the clinical trial is to compare growth in infants (expressed as weight gain in g/day) consuming a new extensively hydrolyzed formula (EHF) to infants consuming a commercially available EHF.
What is the current status of trial NCT01210391?
This trial is currently completed. It is a NA study. The enrollment target is 282 participants. The study started on 2010-11. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01210391?
The interventions under investigation include: Extensively hydrolyzed casein infant formula (OTHER), Extensively hydrolyzed whey infant formula (OTHER).
Who is sponsoring clinical trial NCT01210391?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.